CGC

Canopy Growth

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 19.8%
Negative

Positive
The Motley Fool
6 hours ago
Should You Buy This Cannabis Stock While It's Under $2?
Canopy Growth has struggled in recent years due to significant issues in its home market. Although there has been recent progress in the U.S., that is unlikely to change Canopy Growth's prospects.
Should You Buy This Cannabis Stock While It's Under $2?
Positive
The Motley Fool
yesterday
Does Marijuana Rescheduling in the U.S. Make Canopy Growth a Good Buy in 2026?
President Trump signed an executive order to reschedule marijuana in the U.S., which will make it easier to research the substance. Canopy Growth is a Canada-based producer, which won't benefit from the changes.
Does Marijuana Rescheduling in the U.S. Make Canopy Growth a Good Buy in 2026?
Neutral
Zacks Investment Research
5 days ago
Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.23, marking a -4.65% move from the previous day.
Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts
Neutral
New York Post
6 days ago
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by the president's edict.
Marijuana industry taking fight against Wall Street blockades straight to Trump
Positive
Zacks Investment Research
7 days ago
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Neutral
Business Wire
7 days ago
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebtedness to January 2031 at the earliest. At the conclusion of these Transactions (as defined below), Canopy Gro.
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
Negative
Zacks Investment Research
15 days ago
Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.16, marking a -4.13% move from the previous day.
Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights
Neutral
MarketBeat
15 days ago
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should have sparked a sustained rally.
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
Negative
WSJ
16 days ago
Trump Is Warming to Cannabis, but Investors Aren't Impressed
Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.
Trump Is Warming to Cannabis, but Investors Aren't Impressed
Positive
The Motley Fool
17 days ago
Do These 2 Cannabis Stocks Have a Future?
Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are two leaders in the Canadian market that could turn their attention here. Even with this recent progress, though, neither stock has attractive prospects.
Do These 2 Cannabis Stocks Have a Future?